Most Recent
A judge considering bids to de-class COVID-19 business interruption class actions has said group members can sign up for the representative proceedings but later decide to make claims directly with their insurers.
A judge has rejected a bid by in-fighting group members to bar children and non-Aboriginal residents in the Wreck Bay community from receiving a cut of an approved $22 million settlement over alleged PFAS contamination.
The Australian Competition and Consumer Commission has taken eHarmony Inc to court, alleging the dating site misled users about its advertised 'free dating' membership and that its automatic renewal was a “subscription trap”.
The Australian Securities and Investments Commission has won its case against Finnish microloan company Ferratum alleging it overcharged vulnerable, low-income consumers during the height of the COVID-19 pandemic.
Law firms are facing a historic growth in expenses, despite lawyers becoming notably less productive, according to a new report on the legal industry.
A shareholder in Adero Law has brought proceedings seeking access to the law firm’s books and records for the period in which the firm was running numerous underpayment group proceedings.
Two law firms that have been jointly running a class action against the NSW government over light rail construction in Sydney are now competing to run the case solo, after their relationship broke down and the funder lost confidence in one of the firms, a court has heard.
A class action against Volkswagen over allegedly deadly Takata airbags has failed a second time after an appeals court found “a merely speculative” risk of rupture was not enough to find the vehicles unacceptable.
A top orthopaedic surgeon and former NSW Australian of the year has argued in his defamation case against Nine that stories detailing his alleged negligence misled the public about medical issues and were the “opposite of public interest” journalism.
A 16-year battle between the federal government and drug maker Sanofi-Aventis over an allegedly unjustified court order that prevented the release of a generic version of blockbuster blood-thinner Plavix has gone to the High Court.